First-in-class Dual HIF Inhibitors Eliminate Multiple Tumor Types in Mice when Combined with Immunotherapy
April 8, 2026
Findings from UMSOP researchers and collaborators point to a promising new strategy for treating a broad range of cancers.
April 8, 2026
Findings from UMSOP researchers and collaborators point to a promising new strategy for treating a broad range of cancers.
April 6, 2026
National recognition highlights Mullins’ leadership in advancing patient-centered health care, health equity, and performance excellence.